| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WDR89 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | TP53TG3F | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | RNF219 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | IGFBP6 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | SLC9B1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | PCBP2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | ARL17A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | FHAD1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | TBC1D5 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | CEL | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
